Series A - MyoKardia
Investment Firm
Overview
MyoKardia is a clinical-stage biopharmaceutical company that develops targeted therapies for the treatment of rare cardiovascular diseases.
Announced Date
Sep 20, 2012
Funding Type
Series A
Highlights
Location
United States, North America
Social
Participant Investors
1
| Investor Name |
|---|
 Third Rock Ventures |
Round Details and Background
MyoKardia raised $38000000 on 2012-09-20 in Series A
MyoKardia is a clinical-stage biopharmaceutical company that develops targeted therapies for the treatment of rare cardiovascular diseases.
Company Funding History
5
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Apr 30, 2015 |  Series B - MyoKardia | 5 | - | 46.0M |
| Aug 22, 2014 | Venture Round - MyoKardia | 6 | - | 10.0M |
| Oct 04, 2012 | Venture Round - MyoKardia | - | 4.0M | |
| Sep 20, 2012 | Series A - MyoKardia | 1 | - | 38.0M |
Recent Activity
There is no recent news or activity for this profile.